At Ranok, we are dedicated to creating the next generation of much safer and more efficacious cancer therapies. Our vision is nothing less than to profoundly transform the lives of patients and their families.”


Weiwen Ying, Ph.D. – Founder & CEO

About Ranok Therapeutics

Ranok is a privately held, pre-clinical stage biopharmaceutical company that is pioneering an innovative targeted protein degradation technology for the discovery and development of novel therapeutics. Ranok was founded by a leadership team composed of industry veterans from both Chinese and American biotech and pharmaceutical companies and is based in two of the world’s leading centers of innovation and medical research: Hangzhou, China and Boston, Massachusetts USA.

Learn More